Technical Analysis for TPST - Tempest Therapeutics, Inc.

Grade Last Price % Change Price Change
D 3.87 6.32% 0.23
TPST closed up 6.32 percent on Monday, March 18, 2024, on 1.49 times normal volume. It ran into resistance at its 50 day moving average.
Earnings due: Mar 20
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Up

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 6.32%
Crossed Above 20 DMA Bullish 6.32%
MACD Bullish Signal Line Cross Bullish 6.32%
Inside Day Range Contraction 6.32%
Up 3 Days in a Row Strength 6.32%
20 DMA Resistance Bearish 12.83%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 16 hours ago
Rose Above Upper Bollinger Band about 16 hours ago
Upper Bollinger Band Resistance about 16 hours ago
Rose Above 50 DMA about 16 hours ago
50 DMA Resistance about 16 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tempest Therapeutics, Inc. Description

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecules that combine targeted and immune-mediated mechanisms with the potential to treat various tumors. The company's two novel clinical programs are TPST-1495 and TPST-1120, antagonists of EP2/EP4 and PPARa. Its TPST-1495 and TPST-1120 are advancing through Phase 1 studies designed to study agents as monotherapies and in combination with other approved agents. The company is also developing an orally-available inhibitor of TREX-1 designed to activate selectively the cGAS/STING pathway, an innate immune response pathway important for the development of anti-tumor immunity. The company is headquartered in South San Francisco, California. Tempest Therapeutics Inc. operates as a subsidiary of Inception Sciences, Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Tumor

Is TPST a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.0
52 Week Low 0.17
Average Volume 660,989
200-Day Moving Average 2.54
50-Day Moving Average 3.89
20-Day Moving Average 3.60
10-Day Moving Average 3.48
Average True Range 0.31
RSI (14) 55.75
ADX 12.64
+DI 26.83
-DI 17.17
Chandelier Exit (Long, 3 ATRs) 3.26
Chandelier Exit (Short, 3 ATRs) 3.95
Upper Bollinger Bands 4.08
Lower Bollinger Band 3.13
Percent B (%b) 0.78
BandWidth 26.17
MACD Line -0.09
MACD Signal Line -0.13
MACD Histogram 0.0354
Fundamentals Value
Market Cap 74.49 Million
Num Shares 19.2 Million
EPS -2.20
Price-to-Earnings (P/E) Ratio -1.76
Price-to-Sales 0.00
Price-to-Book 8.69
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.53
Resistance 3 (R3) 4.53 4.30 4.42
Resistance 2 (R2) 4.30 4.14 4.31 4.38
Resistance 1 (R1) 4.09 4.03 4.20 4.09 4.35
Pivot Point 3.86 3.86 3.92 3.87 3.86
Support 1 (S1) 3.65 3.70 3.76 3.65 3.39
Support 2 (S2) 3.42 3.59 3.43 3.36
Support 3 (S3) 3.21 3.42 3.32
Support 4 (S4) 3.21